Search results
26 wrz 2024 · Non-small-cell lung cancer accounts for ~85% of lung cancers. In this Primer, Hendriks et al. summarize current knowledge and research on this malignancy, discussing its epidemiology,...
21 maj 2015 · Metrics. Abstract. Lung cancer is one of the most frequently diagnosed cancers and is the leading cause of cancer-related death worldwide. Non-small-cell lung cancer (NSCLC), a...
17 cze 2024 · In this Review, the authors provide an overview of the epidemiology, diagnosis, prognosis and treatment of patients with lung cancers harbouring these rare alterations.
The focus of this review is to highlight recent data in screening for lung cancer, management of patients with early and locally-advanced non-small cell lung cancer, as well as management of patients with metastatic disease.
Drug formulations derived from natural compounds, such as paclitaxel, doxorubicin, and camptothecin, have been successfully used as chemotherapeutics for lung cancer. In recent years, hundreds of new natural compounds that can be used to treat lung cancer have been found through basic and sub-clinical research.
3 dni temu · According to the latest statistical report [], lung cancer ranks second in terms of estimated new cancer cases and first in terms of estimated cancer-related deaths.Furthermore, its five-year survival rate is relatively low compared to other cancers, standing at only 25% [].Nevertheless, the incidence of lung cancer and the number of deaths due to lung cancer are progressively decreasing ...
14 lip 2021 · This Seminar provides an overview of advances in the screening, diagnosis, and treatment of non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC), with a particular focus on targeted therapies and immune checkpoint inhibitors (ICIs).
